相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Decision tree models to classify nanomaterials according to the DF4nanoGrouping scheme
Agnieszka Gajewicz et al.
NANOTOXICOLOGY (2018)
Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?
Stefan Muhlebach
ADVANCED DRUG DELIVERY REVIEWS (2018)
Nanotoxicology and nanomedicine: making development decisions in an evolving governance environment
Taylor Rycroft et al.
JOURNAL OF NANOPARTICLE RESEARCH (2018)
High throughput toxicity screening and intracellular detection of nanomaterials
Andrew R. Collins et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
Biocompatibility and nanostructured materials: applications in nanomedicine
Mahdi Adabi et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2017)
Safety assessment of nanomaterials using an advanced decision-making framework, the DF4nanoGrouping
Robert Landsiedel et al.
JOURNAL OF NANOPARTICLE RESEARCH (2017)
Challenges associated and approaches for successful translation of nanomedicines into commercial products
Vivek Agrahari et al.
NANOMEDICINE (2017)
Quality-by-design of nanopharmaceuticals - a state of the art
Thierry Bastogne
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
How to select a nanosimilar
Alain Astier et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Equivalence of complex drug products: advances in and challenges for current regulatory frameworks
Leonie Hussaarts et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Nanomedicines in the EU-Regulatory Overview
Ruben Pita et al.
AAPS JOURNAL (2016)
Nano on reflection A number of experts from different areas of nanotechnology describe how the field has evolved in the last ten years
Julia R. Bursten et al.
NATURE NANOTECHNOLOGY (2016)
Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice
Josje H. E. Arts et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk
Pedro M. Costa et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Regulatory aspects on nanomedicines
Vanessa Sainz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Keeping it real: The importance of material characterization in nanotoxicology
Bengt Fadeel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars
Stefan Muehlebach et al.
NANOMEDICINE (2015)
Nanotoxicology: advances and pitfalls in research methodology
Morteza Azhdarzadeh et al.
NANOMEDICINE (2015)
Comparative assessment of nanomaterial definitions and safety evaluation considerations
Darrell R. Boverhof et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges
Saber M. Hussain et al.
TOXICOLOGICAL SCIENCES (2015)
Nanomaterials in consumer products: a challenging analytical problem
Catia Contado
FRONTIERS IN CHEMISTRY (2015)
Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project
Lucienne Juillerat-Jeanneret et al.
NANOTOXICOLOGY (2015)
Structure-activity relationship models for hazard assessment and risk management of engineered nanomaterials
Ceyda Oksel et al.
NEW PARADIGM OF PARTICLE SCIENCE AND TECHNOLOGY, PROCEEDINGS OF THE 7TH WORLD CONGRESS ON PARTICLE TECHNOLOGY (2015)
How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
Huub Schellekens et al.
AAPS JOURNAL (2014)
Nanomedicines: addressing the scientific and regulatory gap
Sally Tinkle et al.
ANNALS REPORTS (2014)
Techniques for physicochemical characterization of nanomaterials
Ping-Chang Lin et al.
BIOTECHNOLOGY ADVANCES (2014)
Nanotherapeutics in the EU: an overview on current state and future directions
Anita Hafner et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Issues and concerns in nanotech product development and its commercialization
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A critical appraisal of existing concepts for the grouping of nanomaterials
Josje H. E. Arts et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
Protein corona formation around nanoparticles - from the past to the future
Pablo Del Pino et al.
MATERIALS HORIZONS (2014)
Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery
Ryan M. Pearson et al.
FRONTIERS IN CHEMISTRY (2014)
Nanotoxicological classification system (NCS) - A guide for the risk-benefit assessment of nanoparticulate drug delivery systems
Cornelia M. Keck et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Nanosafety: towards safer design of nanomedicines
B. Fadeel
JOURNAL OF INTERNAL MEDICINE (2013)
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines
Falk Ehmann et al.
NANOMEDICINE (2013)
A tiered approach
Maxine J. McCall et al.
NATURE NANOTECHNOLOGY (2013)
Considerations on the EU definition of a nanomaterial: Science to support policy making
Eric A. J. Bleeker et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2013)
Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential
David A. Winkler et al.
TOXICOLOGY (2013)
Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials
Bengt Fadeel et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2013)
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Xue-Qing Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Alexandre Albanese et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)
Biomolecular coronas provide the biological identity of nanosized materials
Marco P. Monopoli et al.
NATURE NANOTECHNOLOGY (2012)
Predictive Modeling of Chemical Hazard by Integrating Numerical Descriptors of Chemical Structures and Short-term Toxicity Assay Data
Ivan Rusyn et al.
TOXICOLOGICAL SCIENCES (2012)
Nanotoxicology and in vitro studies: The need of the hour
Sumit Arora et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Protein Adsorption Patterns and Analysis on IV Nanoemulsions—The Key Factor Determining the Organ Distribution
Cornelia Keck et al.
Pharmaceutics (2012)
Quality by Design and Process Analytical Technology for Sterile Products-Where Are We Now?
Bryan S. Riley et al.
AAPS PHARMSCITECH (2011)
State of the art of nanocrystals - Special features, production, nanotoxicology aspects and intracellular delivery
Rainer H. Mueller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
In silico toxicology - non-testing methods
Hannu Raunio
FRONTIERS IN PHARMACOLOGY (2011)
Computational Toxicology: Realizing the Promise of the Toxicity Testing in the 21st Century
Ivan Rusyn et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
G. Oberdorster
JOURNAL OF INTERNAL MEDICINE (2010)
Current Concepts: Nanomedicine.
Betty Y. S. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Alexandra Kroll et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Quality by design approach to understand the process of nanosuspension preparation
Sudhir Verma et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Understanding biophysicochemical interactions at the nano-bio interface
Andre E. Nel et al.
NATURE MATERIALS (2009)
Characterization of nanomaterials for toxicity assessment
Christie M. Sayes et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2009)
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
Wim H. De Jong et al.
BIOMATERIALS (2008)
How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization?
David B. Warheit
TOXICOLOGICAL SCIENCES (2008)
Nanomedicine: An unresolved regulatory issue
Vivian S. W. Chan
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Toxic potential of materials at the nanolevel
A Nel et al.
SCIENCE (2006)
Nanotoxicology:: An emerging discipline evolving from studies of ultrafine particles
G Oberdörster et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2005)
分享论文
